Telum Therapeutics appoints Dr. Subhendu Basu as CEO

Go back to Telum Therapeutics appoints Dr. Subhendu Basu as CEO
(NYSE: PHGE) Delayed: 1.85 --0 (-0%)
Previous Close $1.85    52 Week High
Open $1.85    52 Week Low
Day High $1.85    P/E N/A 
Day Low $1.85    EPS
Volume 87,913